Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
NCT: NCT04753840 · RECRUITING
Brief Summary
According to the latest survey data of China hypertension annual meeting, there are about 300 million patients with hypertension in China, with 10 million new cases of hypertension each year, and there is an obvious trend of younger people. In particular, young and middle-aged people are in a state of mild hypertension for a long time, which causes great pressure on health and medical treatment. At present, the main clinical measures for mild hypertension are to change their eating habits, quit smoking and alcohol, exercise and other lifestyle changes, as well as drug control. For most patients with mild hypertension, drug control is not the best choice. It has been reported that remote ischemic preconditioning (RIPC) may play an effective role in reducing blood pressure .The purpose of this study was to investigate the extent of long-term application of RIPC to reduce blood pressure in patients with mild hypertension.
Frequently Asked Questions
What is Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension?
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension is a clinical trial registered under NCT04753840. Current status: RECRUITING.
What is the status of NCT04753840?
The current status of NCT04753840 (Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension) is: RECRUITING.
When did Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension start?
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension started on 2021-07-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.